Valeant Pharmaceuticals International, Inc. (NYSE: VRX) revealed that it would make available an enhanced rebate program to cut the prices of Nitropress, as well as, Isuprel. The move comes after a ...
As Joe Papa begins the difficult task this week of reviving Valeant Pharmaceuticals, he may want to start by repairing relations with hospitals. The drug maker angered many hospital officials early ...
The Food and Drug Administration has approved a generic version of Valeant Pharmaceuticals' heart drug Nitropress, according to its website, and shares of Valeant are down almost 5% on the news. "This ...
The FDA has approved a generic version of Valeant's Nitropress. Here’s a solution for the hospitals that say they’re still waiting on the discounts Valeant promised for price-jacked heart med ...
Dr. Reddy’s is introducing sodium nitroprusside injection. The product is the generic of Hospira’s Nitropress (sodium nitroprusside) Injection, 50 mg/2mL vial. The Nitropress brand and generics had a ...
Xiromed is introducing sodium nitroprusside injection, in a dosage strength of 50 mg/2 mL (25 mg/mL). The medication is the generic of Nitropress. [Read more: Xiromed unveils generic Extina] It is ...
(RTTNews) - Dr. Reddy's Laboratories Ltd. (RDY), an integrated pharmaceutical company, announced the launch of Sodium Nitroprusside Injection single-dose Vial, the therapeutic generic equivalent of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results